Skip to main content
# Title Department Research Member Research Year
51 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Walaa Talaat Kamel 2024
52 Quantitative and qualitative Assessment of Superficial lymph nodes by B mode ultrasound, colour Doppler and sonoElastography Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2024
53 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
54 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2024
55 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Prof. Amro Farouk ِAhmedMourad 2024
56 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Asmaa Mohamed Zahran Omar 2024
57 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2024
58 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Hadeer Mohamed Saad Elshazly 2024
59 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2024
60 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024